Action 300016 BEIJING BEILU PHARMACEUTICAL CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Beijing Beilu Pharmaceutical Co., Ltd

Actions

300016

CNE000001QK9

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
4,59 CNY +2,23% Graphique intraday de Beijing Beilu Pharmaceutical Co., Ltd -10,87% -35,53%
21/04 Beijing Beilu Pharmaceutical Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Beijing Beilu Pharmaceutical Co. Ltd publie ses résultats pour les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million.
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Beijing Beilu Pharmaceutical Co., Ltd Announces Cash Dividend on A Shares for 2022, Payable on May 25, 2023
Beijing Beilu Pharmaceutical Co., Ltd Approves Cash Dividend for 2022
Beijing Beilu Pharmaceutical Co., Ltd Proposes Final Cash Dividend for the Year 2022
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Beijing Beilu Pharmaceutical Co.,Ltd Announces the Implementation of Cash Dividend for 2019, Payable on 29 April 2022
Beijing Beilu Pharmaceutical Co., Ltd Elects Board Members
Beijing Beilu Pharmaceutical Co., Ltd. Announces Final Cash Dividend for Year 2021
Beijing Beilu Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
Beijing Beilu Pharmaceutical Co., Ltd. Approves Profit Distribution for 2020
Beijing Beilu Pharmaceutical : Proposes Final Dividend for 2020
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300016
  4. Actualités Beijing Beilu Pharmaceutical Co., Ltd
  5. Autres langues